In its first day of trading on the New York Stock Exchange, Envista Holdings—the Danaher dental business spinoff—debuted at $25.65 per share, 16.59% above its opening price of $22.

Trading closed at $27.95, up 27.05% from its opening price.

Envista includes the Ormco, KaVo Kerr, and Nobel Biocare dental brands.

With its IPO, the company raised over $588 million after pricing over 26.7 million shares at $22 per share.